Total synthesis approaches to natural product derivatives based on the combination of chemical synthesis and metabolic engineering
- 10 September 2007
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 5 (20), 3245-3259
- https://doi.org/10.1039/b709549j
Abstract
Secondary metabolites are an extremely diverse and important group of natural products with industrial and biomedical implications. Advances in metabolic engineering of both native and heterologous secondary metabolite producing organisms have allowed the directed synthesis of desired novel products by exploiting their biosynthetic potentials. Metabolic engineering utilises knowledge of cellular metabolism to alter biosynthetic pathways. An important technique that combines chemical synthesis with metabolic engineering is mutasynthesis (mutational biosynthesis; MBS), which advanced from precursor-directed biosynthesis (PDB). Both techniques are based on the cellular uptake of modified biosynthetic intermediates and their incorporation into complex secondary metabolites. Mutasynthesis utilises genetically engineered organisms in conjunction with feeding of chemically modified intermediates. From a synthetic chemist's point of view the concept of mutasynthesis is highly attractive, as the method combines chemical expertise with Nature's synthetic machinery and thus can be exploited to rapidly create small libraries of secondary metabolites. However, in each case, the method has to be critically compared with semi- and total synthesis in terms of practicability and efficiency. Recent developments in metabolic engineering promise to further broaden the scope of outsourcing chemically demanding steps to biological systems.Keywords
This publication has 80 references indexed in Scilit:
- Natural Products as Sources of New Drugs over the Last 25 YearsJournal of Natural Products, 2007
- Generation of New Landomycins with Altered Saccharide Patterns through Over‐expression of the Glycosyltransferase Gene lanGT3 in the Biosynthetic Gene Cluster of Landomycin A in Streptomyces cyanogenus S‐136ChemBioChem, 2006
- Total Synthesis and Antitumor Activity of ZK‐EPO: The First Fully Synthetic Epothilone in Clinical DevelopmentAngewandte Chemie, 2006
- Total Synthesis of Narbonolide and Biotransformation to PikromycinThe Journal of Organic Chemistry, 2006
- Precursor-directed biosynthesis of 6-deoxyerythronolide B analogues is improved by removal of the initial catalytic sites of the polyketide synthaseJournal of Industrial Microbiology & Biotechnology, 2006
- Antibody-Drug Conjugates Designed to Eradicate Tumors with Homogeneous and Heterogeneous Expression of the Target AntigenCancer Research, 2006
- The biosynthesis, molecular genetics and enzymology of the polyketide-derived metabolitesNatural Product Reports, 2005
- Combinatorial biosynthesis of lipopeptide antibiotics in Streptomyces roseosporusJournal of Industrial Microbiology & Biotechnology, 2005
- Mutasynthesis of Rapamycin Analogues through the Manipulation of a Gene Governing Starter Unit BiosynthesisAngewandte Chemie, 2005
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003